Cardio-Hepatology. Connections Between Hepatic and Cardiovascular Disease

Table of Contents

I. Liver and heart 1. The liver
2. Nonalcoholic fatty liver disease and cardiovascular disease 3. Pathophysiologic changes in chronic heart failure affecting drug pharmacokinetics 4. Drugs at the crossroads of heart and liver 5. Obstruction of the liver circulation

II. Hepatobiliary system in heart failure 6. Epidemiology of liver diseases in heart failure 7. Cardio-hepatology: liver function tests in heart failure 8. Prognostic value of liver assessment (including liver stiffness measurement) in cardiovascular diseases 9. Passive liver congestion and hypoxic hepatitis 10. Histopathology of the liver in heart failure

III. Cardiovascular system in liver failure 12. Sepsis and the liver 13. Bleeding and thrombosis in cirrhosis 14. Peripheral vasculature in portal hypertension 15. Cirrhotic cardiomyopathy 16. Cardiovascular dysfunction in liver diseases: pediatric perspectives 17. Hepatorenal syndrome and acute kidney injury in cirrhosis 18. Cardiopulmonary considerations for the anesthetic management of liver transplantation 19. Cardiovascular assessment before liver transplantation 20. Predicting cardiovascular complications after liver transplantation

Authors

Tatsunori Taniguchi Professor and Cardiologist of the Medical Staff, Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan. Dr. Taniguchi is a cardiologist at the Department of Cardiovascular Medicine at Osaka University Graduate School of Medicine, Japan, with research interests in crosstalk between heart and other organs in heart failure. He has won several awards for research including the 2014 Japan Circulation Society (Kinki Regional Scientific Meeting) Young Investigator's Award and the Japan Society of Ultrasound Sonics in Medicine Prize for Encouragement. He served as a representative of U-40 heart failure network in Japan in 2018. He is also a member of Japan International Young Committee at Japan Circulation Society from 2018. Samuel S. Lee Division of Gastroenterology, The University of Calgary, Calgary, Alberta, Canada. Dr. Lee is a professor of Medicine (Hepatology) at the University of Calgary, Canada, with research interests in cardiovascular complications of cirrhosis and viral hepatitis. He has won several awards for teaching and research including the Queen Elizabeth II Golden Jubilee Medal in 2002, the Canadian Association of the Study of Liver (CASL) Distinguished Service Award, 2015, CASL/CLF Gold Medal in 2021, and has lectured in more than 50 countries. He is a past-president of CASL, International Association for Study of Liver (IASL), and the International Ascites Club. He served as editor-in-chief of Liver International from 2008 to 2013. He chairs the steering committee for the Canadian HCV database registry CANUHC (Canadian Network Undertaking against Hepatitis C).